5//SEC Filing
OxySure Therapeutics, Inc. 5
Accession 0001547522-16-000213
CIK 0001413797operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 5:19 PM ET
Size
6.4 KB
Accession
0001547522-16-000213
Insider Transaction Report
Form 5
JONES JEREMY M
Director
Transactions
- Other
Common stock
2016-02-15$0.18/sh+50,000$9,250→ 182,474 total(indirect: By Trust)
Holdings
- 132,474(indirect: By Trust)
Common stock
- 181,818(indirect: By Trust)
Common stock
Footnotes (1)
- [F1]Acquired as an incentive for extending the due date of certain payment obligations by the Company.
Documents
Issuer
OxySure Therapeutics, Inc.
CIK 0001413797
Entity typeoperating
Related Parties
1- filerCIK 0001413797
Filing Metadata
- Form type
- 5
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 5:19 PM ET
- Size
- 6.4 KB